Skip to content

News & Knowledge

“Trio of Favorable Preemption Decisions for NJ Pharma Cos.,” Law360

Knowledge

“Trio of Favorable Preemption Decisions for NJ Pharma Cos.,” Law360

August 21, 2013
H. Lockwood Miller III

“A trio of recent preemption decisions — from the U.S. Supreme Court, the U.S. District Court for the District of New Jersey and the New Jersey Superior Court, Atlantic and Cape May Counties — are good news for pharmaceutical companies facing product liability suits in New Jersey,” writes H. Lockwood (Chip) Miller III, a partner in Goldberg Segalla’s Product Liability and Life Sciences Practice Groups.

In this Law360 Expert Analysis feature, Chip examines these important rulings and their impact on both brand-name and generic pharmaceutical manufacturers.

Read the article here: